Organogenesis Holdings Inc. (ORGO) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.
The consensus price target is $9.00, representing an upside of 258.6% from the current price $2.51.
Analysts estimate Earnings Per Share (EPS) of $-0.07 and revenue of $0.47B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.01 vs est $-0.07 (beat +86.4%). 2025: actual $0.16 vs est $0.15 (beat +5.5%). Analyst accuracy: 0%.
ORGO Stock — 12-Month Price Forecast
$9.00
▲ +258.57% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Organogenesis Holdings Inc., the price target is $9.00.
The average price target represents a +258.57% change from the last price of $2.51.
ORGO Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Organogenesis Holdings Inc. in the past 3 months
EPS Estimates — ORGO
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.01
vs Est –$0.07
▲ 633.3% off
2025
Actual $0.16
vs Est $0.15
▲ 5.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Revenue Estimates — ORGO
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.482B
vs Est $0.466B
▲ 3.4% off
2025
Actual $0.564B
vs Est $0.511B
▲ 9.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
